As previously reported, UBS upgraded ASML (ASML) to Buy from Neutral with a price target of EUR 750, up from EUR 660. With the stock down about 20% following a year of underperformance, the firm views the overhang from the Chinese market as “well understood by the market,” the analyst tells investors. In 2027 the firm sees the return of ASML as “a quality compounder” delivering a 20% EPS compound annual growth rate from 2026-2030, the analyst added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASML:
- ASML upgraded to Buy from Neutral at UBS
- ASML price target raised to EUR 680 from EUR 650 at Barclays
- ASML price target lowered to EUR 724 from EUR 755 at BofA
- ASML Holding NV: Undervalued with Strong Long-Term Growth Prospects Despite Near-Term Challenges
- Largest borrow rate increases among liquid names